Pharmaceutical Commerce
CONTINUE TO SITE >

OR WAIT 15 SECS

Pharmaceutical Commerce - May/June 2016

Clinical cold chain vendors go into a deep freeze

May 11, 2016

Demand for cryogenic logistics propels business growth

Brand enhancement and safety with unit-dose packaging

May 10, 2016

Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging

Changing the payment paradigm

May 10, 2016

Policymakers look at alternative payment models in oncology

Specialty pharmacy dynamics

May 09, 2016

The SP channel continues to grow, with manufacturers looking for more control over access

Laying the foundation for a national system for evidence generation

May 06, 2016

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis

Copay assistance data on the iPad: TrialCard’s new app

April 28, 2016

Integrating copay programs with multichannel marketing

Prescription-drug abuse legislation signed into law

April 19, 2016

Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) calls for better industry-government coordination

More injectables capacity in the US, Germany

April 05, 2016

Novo Nordisk and Vetter Pharma announce groundbreakings

FDA proposes guidance for biosimilar product labels

April 05, 2016

Labels will have a combination of reference-product and biosimilar-specific information

Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute

March 29, 2016

Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians

ZS Associates sharpens focus on pharma-physician interaction

March 25, 2016

'Customer Experience Tracker' measures success in oncologist interactions